Canine Cancers
EnGeneIC is currently carrying out research case studies in dogs suffering from several different types of cancers including hemangiosarcoma, brain cancer and lymphoma. The aim is to study the safety, toxicity and efficacy in animals with endogenous tumours, i.e. not mouse xenografts. These studies are not a clinical trial and are only research case studies. The dogs are at two of Sydney’s specialist veterinary oncology clinics, and along with key scientists from EnGeneIC, several veterinary clinical oncologists are involved in these studies

|
|
Targeted Drug Delivery
Gene Silencing
Canine Cancers
Principal Characteristics |